Association between the COVID-19 outbreak and opioid prescribing by U.S. dentists.

ABSTRACT:

Background

U.S. data on opioid prescribing by dentists are limited to 2019. More recent data are needed to understand the effect of the COVID-19 outbreak on dental opioid prescribing, characterize current practices, and determine if dental opioid stewardship initiatives are still warranted.

Objective

To evaluate the association between the COVID-19 outbreak and the rate of opioid prescribing by U.S. dentists.

Methods

During February-April 2023, the authors conducted a cross-sectional analysis of the IQVIA Longitudinal Prescription Database, which reports 92% of prescriptions dispensed in U.S. retail pharmacies. The authors calculated the monthly dental opioid dispensing rate, defined as the monthly number of dispensed opioid prescriptions from dentists per 100,000 U.S

SUBMITTER: Zhang J 

PROVIDER: S-EPMC10621808 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature